Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05714111

Radiology Registry on Pancreatic Malignancies

The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pancreatic Cancer Cysts Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Neoplasms Neoplasms by Site Pancreas Cyst Pancreas Disease Pancreas Neoplasm Pancreatic Cyst Pancreatic Diseases Pancreatic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Radiology, IRCCS Ospedale San Raffaele

Milan, 20132, Italy

Location status: Recruiting

Location contact

Diego Palumbo, MD

PRINCIPAL_INVESTIGATOR

Francesco De Cobeli, MD

CONTACT

[email protected]

+39022643 ext. 2529

Stephanie Steidler, PhD

CONTACT

[email protected]

+39022643 ext. 6111

About this study

Single center, observational (retrospective and prospective) will collect all available parameters to assess the clinical outcome of the patients (progression free survival (PFS), overall survival (OS), local progression free survival LTPFS), response to treatment) with pancreatic neoplasms presenting to San Raffaele. Patient assignment to a given diagnostic and/or therapeutic procedure is not related to random assignment methods but is part of the ordinary therapeutic strategy planned for each patient on an individual basis and after multidisciplinary discussion.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥18 years of age
  • Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage.
  • able and willing to sign informed consent

Exclusion criteria

  • Patients with non-primary pancreatic disease

Treatment and study plan

Radiology evaluations and interventions

Other

Diagnostic and interventional radiology procedures

Primary outcomes

  1. Progression- free survival

    Time frame: From date of intervention until the date of first documented progression, up to a maximum of 3 years

    Time from start of observation to disease progression

  2. Local progression free survival

    Time frame: From date of intervention until the date of first documented local progression assessed up to a maximum of 3 years

    Time between (start of) a locoregional treatment and local disease progression

Secondary outcomes

  1. Overall Survival

    Time frame: From date of treatment until the date of death from any cause assessed up to 3 years

    The length of time from either the date of diagnosis or the start of treatment for a disease, in which the patients are still alive

Sponsors and collaborators

Lead sponsor

IRCCS San Raffaele

Other

Registry information

Acronym: RadonPams

Important dates

Study start
2022
Primary completion
2027
Study completion
2030
First posted
Feb 6, 2023
Registry last updated
Apr 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.